rs11555566

This is a protein-altering variant in the ADA gene.

GWAS Catalog Trait Associations (3)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

adenosine deaminase measurement

Allele T
OR 1.07
p
N 14,736
Large GWAS
multi-ancestry
Kalnapenkis A et al. Genetic determinants of plasma protein levels in the Estonian population. Scientific Reports 14(1):7694 (2024)
Allele T
OR 1.25
p 8.0e-32
N 489
Small GWAS
European

adenosine measurement

Feofanova EV et al. Whole-Genome Sequencing Analysis of Human Metabolome in Multi-Ethnic Populations. Nature Communications 14(1):3111 (2023)
Allele C
OR 0.34
p 6.0e-38
N 10,155
Large GWAS
multi-ancestry

serum metabolite level

Allele T
OR 0.40
p 4.0e-26
N 3,926
Large GWAS
Hispanic or Latin American

ClinVar annotation

Benign★★★★
12 submitters6 publications

Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency; not specified

View on ClinVar →

About ADA

This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine in the purine catabolic pathway. Various mutations have been described for this gene and have been linked to human diseases related to impaired immune function such as severe combined immunodeficiency disease (SCID) which is the result of a deficiency in the ADA enzyme. In ADA-deficient individuals there is a marked depletion of T, B, and NK lymphocytes, and consequently, a lack of both humoral and cellular immunity. Conversely, elevated levels of this enzyme are associated with congenital hemolytic anemia. [provided by RefSeq, Sep 2019]

View all ADA variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…